The current guideline-recommended creatinine-based eGFR equation incorporates a race coefficient that may overestimate eGFR in Black adults and contribute to discordant care.
Using changes in UACR and eGFR as an alternative outcome for kidney failure in trials of CKD progression warrants further evaluation, according to investigators.
High variability in body mass index is associated with an increased risk for death, requiring kidney replacement therapy, myocardial infarction, and stroke, investigators concluded.
